Increased susceptibility to genital herpes in medroxyprogesterone-treated mice may provide a surrogate of increased HIV risk and a preclinical biomarker of topical preexposure prophylaxis safety. well tolerated and did not result in any increase in HSV-2 susceptibility but guarded HCL Salt mice from herpes simplex virus 2 (HSV-2) disease compared to mice treated with the… Continue reading Increased susceptibility to genital herpes in medroxyprogesterone-treated mice may provide a